Atlas Trials

Effects of 5 Weeks Treatment With Dapagliflozin in Type 2 Diabetes Patients on How the Hormone Insulin Acts on Sugar Uptake in Muscles.

Clinical trial NCT03338855 · COMPLETED

Trial details

NCT number
NCT03338855
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2Skeletal Muscle Insulin Sensitivity
Start date
2018-03-05
Primary completion
2019-11-04
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.